LOMTEGOVIMAB
UNII 7EPY8J7EVF

Substance Identification & Data

This profile provides standardized clinical and technical data for Lomtegovimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 7EPY8J7EVF.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2550869-33-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

7EPY8J7EVF

CAS Registry Number

2550869-33-3

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

LOMTEGOVIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C183320

National Cancer Institute reference terminology for clinical and research data.

INN ID

12001

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Lomtegovimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

LOMTEGOVIMAB

Common Names & Synonyms

BI 767551 [WHO-DD]

IMMUNOGLOBULIN G1 (DE-C-TERMINAL-LYSINE), ANTI-(SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 SPIKE GLYCOPROTEIN RECEPTOR-BINDING DOMAIN) (HUMAN MONOCLONAL BI00767551 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL BI00767551 .KAPPA.-CHAIN, DIMER

LOMTEGOVIMAB [INN]